BiotechTube
Home/axelyf/Daniel Omar Frímannsson, PhD
DO

Daniel Omar Frímannsson, PhD

Head of Nucleic Acid Technologies and Biology

axelyf

Therapeutic Areas

OncologyAutoimmune Diseases

axelyf Pipeline

DrugIndicationPhase
AX-004Solid Tumors (in vivo CAR-T)Pre-clinical
AX-003Autoimmune HepatitisPre-clinical

Leadership Team at axelyf

ÖA
Örn Almarsson, PhD
CEO, Co-founder
JL
John Lucas, JD, PhD
Chief Counsel, Co-founder
YX
Yan Xia, PhD
Head of Nanotechnology Formulations
AS
Arnar Sigurðsson, PhD
Principal Scientist
View full axelyf profile